{"name":"Thrasos","permalink":"thrasos","crunchbase_url":"http://www.crunchbase.com/company/thrasos","homepage_url":"http://www.thrasos.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":null,"number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@thrasos.com","phone_number":"514-940-2714","description":"","created_at":"Fri Oct 26 03:43:49 UTC 2012","updated_at":"Fri Oct 26 03:51:51 UTC 2012","overview":"<p>Thrasos is a bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of severe organ failure, with a principle focus on kidney disease. The Company&#8217;s lead therapeutic program, THR-184, is focused on the prevention and treatment of acute kidney injury (AKI). The Company also has a preclinical development program for treating chronic kidney disease (CKD).</p>","image":{"available_sizes":[[[150,56],"assets/images/resized/0021/7327/217327v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0021/7327/217327v1-max-250x250.jpg"],[[252,95],"assets/images/resized/0021/7327/217327v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Chief Medical Officer","person":{"first_name":"Dr.","last_name":"Andreas Orfanos","permalink":"dr-andreas-orfanos","image":null}},{"is_past":false,"title":"President and Chief Executive Officer","person":{"first_name":"Richard","last_name":"Andrews","permalink":"richard-andrews","image":null}},{"is_past":false,"title":"Senior Vice President, Research and Development","person":{"first_name":"Dr.","last_name":"Philippe Bey","permalink":"dr-philippe-bey","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$35M","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.businesswire.com/news/edmontonjournal/20121025005392/en/Thrasos-Secures-35-Million-Fund-THR-184-Phase","source_description":"Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":25,"investments":[{"company":null,"financial_org":{"name":"SR One","permalink":"sr-one","image":{"available_sizes":[[[150,58],"assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],[[206,81],"assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],[[206,81],"assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Advanced Technology Ventures","permalink":"advanced-technology-ventures","image":{"available_sizes":[[[150,27],"assets/images/resized/0002/1155/21155v1-max-150x150.png"],[[250,45],"assets/images/resized/0002/1155/21155v1-max-250x250.png"],[[394,72],"assets/images/resized/0002/1155/21155v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Fonds de solidaritÃ© FTQ","permalink":"fonds-de-solidarit-ftq","image":{"available_sizes":[[[150,77],"assets/images/resized/0006/1164/61164v1-max-150x150.png"],[[177,91],"assets/images/resized/0006/1164/61164v1-max-250x250.png"],[[177,91],"assets/images/resized/0006/1164/61164v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Lumira Capital","permalink":"lumira-capital","image":{"available_sizes":[[[150,53],"assets/images/resized/0013/3918/133918v1-max-150x150.jpg"],[[228,81],"assets/images/resized/0013/3918/133918v1-max-250x250.jpg"],[[228,81],"assets/images/resized/0013/3918/133918v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"MP Healthcare Venture Management","permalink":"mp-healthcare-venture-management-inc","image":{"available_sizes":[[[150,17],"assets/images/resized/0005/0688/50688v2-max-150x150.png"],[[250,28],"assets/images/resized/0005/0688/50688v2-max-250x250.png"],[[397,46],"assets/images/resized/0005/0688/50688v2-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Pappas Ventures","permalink":"pappas-ventures","image":{"available_sizes":[[[150,131],"assets/images/resized/0004/9245/49245v1-max-150x150.png"],[[164,144],"assets/images/resized/0004/9245/49245v1-max-250x250.png"],[[164,144],"assets/images/resized/0004/9245/49245v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"2000 Peel St.","address2":"Suite 900","zip_code":"H3A 2W5","city":"Montreal, QC","state_code":null,"country_code":"CAN","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}